---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-008860"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2024-06-03T23:59:59+00:00"
generated_at: "2026-06-01T06:46:14.251070+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# iBio updates corporate presentation; no financial or operational specifics disclosed

## Summary
- Filed updated investor presentation dated June 2024 under Item 7.01.
- Presentation title: 'Tomorrow's Precision Antibody Therapeutics Powered by Machine Learning'.
- No new financial data, guidance, or material business changes were included in the filing.
- The presentation is furnished, not filed, and not incorporated by reference.
- No forward-looking statements or new milestones were provided beyond prior disclosures.

## SEC filing metadata
- accession: 0001558370-24-008860
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2024-06-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000155837024008860/0001558370-24-008860-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000155837024008860/ibio-20240603x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-008860
- JSON: https://secwatch.observer/filing/0001558370-24-008860.json
- Plain text: https://secwatch.observer/filing/0001558370-24-008860.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.